AKBA vs RDY: Side-by-Side Comparison
Compare Akebia Therapeutics Inc (AKBA) and Dr. Reddy`s Laboratories Ltd (RDY) side by side: market cap USD 332.64M vs USD 11.97B. Financials, growth and model signals on Bullrun.
| Metric | AKBA | RDY |
|---|---|---|
| Company | Akebia Therapeutics Inc | Dr. Reddy`s Laboratories Ltd |
| Country / Exchange | United States · NASDAQ | India · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic | Drug Manufacturers-Specialty & Generic |
| Market cap | USD 332.64M | USD 11.97B |
| P/E ratio | — | 24.5 |
| Dividend yield | — | 0.63% |
| Valuation model | — | 20.9% undervalued |
| Revenue (latest FY) | USD 236.20M | — |
| Revenue growth YoY | +47.5% | — |
| Net income | USD -5.30M | — |
| Gross margin | 83.3% | — |
| Diluted EPS | -0.02 | — |